94Indexed trials
Market Rank #32 · Evidence Tier A
Mexico
Neuroscience Intelligence
Mexico neuroscience intelligence: 94 indexed trials, 31 institutions, research score 33.70.
20Recruiting
31Research institutions
33.7Research score
Evidence profile
49Sponsors
21Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 33.7 · Data confidence 100.00 · Evidence 33.7
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
epilepsy19trials
alzheimers14trials
parkinsons14trials
depression7trials
schizophrenia7trials
other_neurology5trials
multiple_sclerosis5trials
migraine_headache3trials
autism3trials
anxiety2trials
Leading indexed sponsors
Merck Sharp & Dohme LLC8trials
Hoffmann-La Roche8trials
Pfizer7trials
UCB Pharma5trials
Eli Lilly and Company5trials
Boehringer Ingelheim4trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Washington University School of Medicine3trials
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente2trials
Instituto Neurociencia Del Dolor2trials